Steroids: short course prednisolone at diagnosis to induce remission
Conventional Disease Modifying Anti-Rheumatic Drugs (DMARDs) (e.g. methotrexate, leflunomide, sulfasalazine, hydroxychloroquine): commenced early β monotherapy initially, with additional DMARD added if uncontrolled
Biological DMARDs (anti-TNFΞ±, e.g. adalimumab, etanercept, infliximab; or anti-IL6, e.g. sarilumab): can halt or even reverse disease process; offered to patients with severe disease who have not responded to combination DMARDs
Other therapies
Surgery: can improve mobility and reduce pain in patients with deformities